INDU.A

333.4

+1.28%↑

INDU.C

333.8

+1.21%↑

AZA

307.5

-3.61%↓

ORES

119.6

+1.37%↑

INDU.A

333.4

+1.28%↑

INDU.C

333.8

+1.21%↑

AZA

307.5

-3.61%↓

ORES

119.6

+1.37%↑

INDU.A

333.4

+1.28%↑

INDU.C

333.8

+1.21%↑

AZA

307.5

-3.61%↓

ORES

119.6

+1.37%↑

INDU.A

333.4

+1.28%↑

INDU.C

333.8

+1.21%↑

AZA

307.5

-3.61%↓

ORES

119.6

+1.37%↑

INDU.A

333.4

+1.28%↑

INDU.C

333.8

+1.21%↑

AZA

307.5

-3.61%↓

ORES

119.6

+1.37%↑

Search

Biotage AB

Open

140.6 -0.64

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

140.1

Max

141.5

Belangrijke statistieken

By Trading Economics

Inkomsten

97M

158M

Verkoop

92M

582M

K/W

Sectorgemiddelde

25.507

20.525

EPS

1.416

Dividendrendement

1.82

Winstmarge

27.148

Werknemers

680

EBITDA

111M

222M

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

1.82%

4.36%

Volgende Winsten

16 jul 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-3.9B

7.2B

Vorige openingsprijs

141.24

Vorige sluitingsprijs

140.6

Biotage AB Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

22 apr 2025, 06:50 UTC

Acquisities, Fusies, Overnames

KKR Launches $1.2 Billion Takeover Bid For Swedish Life-Sciences Company Biotage

22 apr 2025, 06:04 UTC

Acquisities, Fusies, Overnames

KKR: Offer Price Represents 60% Premium to Thursday's Closing Price

22 apr 2025, 06:03 UTC

Acquisities, Fusies, Overnames

KKR: Biotage Board Recommends Shareholders Accept Offer

22 apr 2025, 06:02 UTC

Acquisities, Fusies, Overnames

KKR: Offer Values Biotage at SEK11.61B

22 apr 2025, 06:02 UTC

Acquisities, Fusies, Overnames

KKR Makes SEK145 a Share Bid For Biotage

Peer Vergelijking

Prijswijziging

Biotage AB Prognose

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Biotage AB

Biotage AB (publ) provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems; sample preparation products; plasmid purification solutions; oligo synthesis solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicology, doping control animal and human, environment, and food and agriculture areas, as well as consumables and systems; protein purification solutions, including antibody and tagged proteins purification, automation systems, and custom packing service, as well as ion exchange, reversed phase, normal phase, and gel filtration PhyTip columns. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, diagnostics, clinical, environmental protection, food safety, clinical, forensic, and academic laboratories industries. It operates in more than 80 countries, which include Americas, Europe, the Middle East, Africa, and Asia Pacific. Biotage AB (publ) was founded in 1969 and is headquartered in Uppsala, Sweden.